Literature DB >> 1910079

A study on the biological behavior of human brain tumors. Part II: Steroid receptors and arachidonic acid metabolism.

G Butti1, P Gaetani, C Chiabrando, R Assietti, C Zibera, M G Castelli, N Gibelli, V Silvani, G Robustelli della Cuna, P Paoletti.   

Abstract

The significance of steroid receptors (SR) in human brain tumors is presently a field of intense investigation in order to clarify some aspects of the biological behavior of these neoplasms. We studied the relationship between the presence of steroid receptors and the production of metabolites of the arachidonic acid cascade which have been reported to have a role in the biological behavior of some human tumors. We found that some metabolites of arachidonic acid are produced in different amounts in brain tumors which either did or did not express some steroid receptors. In particular the PGE2 were higher in estrogen receptors (ER) positive meningiomas than in ER negative ones and 6-keto-PGF1 alpha, the stable metabolite of prostacyclin, is significantly higher in androgen receptors (AR) negative meningiomas than in AR positive ones. In neuroepithelial tumors the glucocorticoid receptors (GR) positive cases synthesized more TxB2 and less PGE2 than the GR negative ones. Our data seem to suggest that some correlations exist between the presence of some steroid receptors and arachidonic acid metabolite production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910079     DOI: 10.1007/bf00177536

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.

Authors:  C Chiabrando; M Broggini; M G Castelli; E Cozzi; M N Castagnoli; M G Donelli; S Garattini; R Giavazzi; R Fanelli
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

2.  Estrogen and progesterone receptors in meningiomas.

Authors:  D W Cahill; N Bashirelahi; L W Solomon; T Dalton; M Salcman; T B Ducker
Journal:  J Neurosurg       Date:  1984-05       Impact factor: 5.115

Review 3.  Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.

Authors:  K V Honn; R S Bockman; L J Marnett
Journal:  Prostaglandins       Date:  1981-05

4.  Prostaglandins, steroids and human mammary cancer.

Authors:  J Watson; S Y Chuah
Journal:  Eur J Cancer Clin Oncol       Date:  1985-09

5.  Control of endometrial prostaglandin output in vitro during the estrous cycle of the guinea-pig: influence of estradiol 17-beta, progesterone, oxytocin and calcium ionophore A23187.

Authors:  H A Leaver; A Seawright
Journal:  Prostaglandins Leukot Med       Date:  1982-12

6.  Some differences in steroid receptors between meningeal and neuroepithelial tumors.

Authors:  G Sica; C Zibera; F O Ranelletti; M Scerrati; G Butti; R Roselli; G F Rossi; G Robustelli Della Cuna
Journal:  J Neurosurg Sci       Date:  1989 Jan-Mar       Impact factor: 2.279

7.  Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas.

Authors:  R L Martuza; D C Miller; D T MacLaughlin
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

8.  Prostaglandin and thromboxane synthesis by human intracranial tumors.

Authors:  M G Castelli; C Chiabrando; R Fanelli; L Martelli; G Butti; P Gaetani; P Paoletti
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

9.  Hormonal manipulation of meningiomas in vitro.

Authors:  J J Olson; D W Beck; J Schlechte; P M Loh
Journal:  J Neurosurg       Date:  1986-07       Impact factor: 5.115

10.  Arachidonic acid metabolic profiles in human meningiomas and gliomas.

Authors:  M G Castelli; G Butti; C Chiabrando; E Cozzi; R Fanelli; P Gaetani; V Silvani; P Paoletti
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

View more
  1 in total

Review 1.  The eicosanoid cascade: possible role in gliomas and meningiomas.

Authors:  N Nathoo; G H Barnett; M Golubic
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.